Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.

Previous research shows generally greater proportional elevation in apolipoprotein B (apoB) levels than in low-density lipoprotein cholesterol (LDL-C) in coronary heart disease (CHD) case subjects compared with control subjects. The Atherosclerosis Risk in Communities study provided general populations of 7261 men and women free of cardiovascular symptoms for evaluating the associations between intima-media thickening in extracranial carotid arteries measured using ultrasound imaging and fasting plasma LDL-C, high-density lipoprotein cholesterol (HDL-C), apoB, apolipoprotein A-I (apoA-I), triglycerides, and HDL density subfractions. A CHD group was selected for comparison. Lipid factors show approximately linear associations with carotid thickness: positive for LDL-C and plasma apoB and negative for HDL-C and apoA-I levels. Apolipoproteins and HDL density subfractions did not contribute to the association after accounting for LDL-C and HDL-C. Compared with control subjects, persons whose carotid thickness exceeded 0.9 mm had greater proportional elevations in LDL-C than in apoB, whereas HDL-C reductions were small. CHD case subjects showed greater proportional elevations of apoB than LDL-C. Although the lipid profiles associated with asymptomatic carotid wall thickening and stenotic coronary disease are similar, the differences found suggest that LDL-C is the most important lipid factor in earlier stages of atherogenesis, whereas the metabolism of triglyceride-rich lipoproteins and its effects on LDL and HDL may be more relevant to later atherothrombotic processes.

[1]  WR Roche,et al.  Basic Pathology , 1994 .

[2]  A. Sharrett Invasive versus noninvasive studies of risk factors and atherosclerosis. , 1993, Circulation.

[3]  P. Wilson,et al.  Change in LDL particle size is associated with change in plasma triglyceride concentration. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  K. Anderson,et al.  Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. , 1992, Journal of the American College of Cardiology.

[5]  P. Wilson,et al.  Low density lipoprotein particle size and coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[7]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[8]  L. Chambless,et al.  High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  L. Chambless,et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.

[10]  M. C. Nuttens,et al.  Relation of Arteriographically Defined Coronary Artery Disease to Serum Lipoprotein Particles Mapped With Monoclonal Antibodies , 1991, Circulation.

[11]  Y. Friedlander,et al.  The Dubbo Study of the Health of Elderly: Correlates of Coronary Heart Disease at Study Entry , 1991, Journal of the American Geriatrics Society.

[12]  George Howard,et al.  High‐resolution B‐Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC) , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[13]  J. Salonen,et al.  Determinants of carotid intima‐media thickness: a population‐based ultrasonography study in Eastern Finnish men , 1991, Journal of internal medicine.

[14]  J. Cooper,et al.  Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. , 1991, Atherosclerosis.

[15]  S. Broste,et al.  Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. , 1990, Archives of internal medicine.

[16]  A. Sharrett,et al.  Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. , 1988, Clinical chemistry.

[17]  E. Ford,et al.  Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease. , 1990, Journal of clinical epidemiology.

[18]  P. Wilson,et al.  Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. , 1990, Clinical chemistry.

[19]  Aric Invest The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[20]  S. Humphries,et al.  Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration. , 1989, Atherosclerosis.

[21]  N. Al-Muhtaseb,et al.  Research paperLipoproteins and apolipoproteins in young male survivors of myocardial infarction , 1989 .

[22]  J. Cruickshank,et al.  Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. , 1989, Atherosclerosis.

[23]  A. Gotto,et al.  A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. , 1989, Clinical chemistry.

[24]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[25]  O. Topolcan,et al.  Lipid and apolipoprotein levels in patients with ischaemic heart disease. A comparative study in Plzen and Moscow. , 1989, Cor et vasa.

[26]  N. Al-Muhtaseb,et al.  Lipoproteins and apolipoproteins in young male survivors of myocardial infarction. , 1989, Atherosclerosis.

[27]  S. Johansson,et al.  Serum lipids and apolipoprotein levels in women with acute myocardial infarction. , 1988, Arteriosclerosis.

[28]  E. Nikkilä,et al.  Serum lipoproteins in patients with myocardial infarction. , 1988, Atherosclerosis.

[29]  C. Furberg,et al.  Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review. , 1988, Stroke.

[30]  C. Luo,et al.  The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. , 1988, Journal of lipid research.

[31]  P. Kwiterovich HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. , 1988, Clinical chemistry.

[32]  A. Gotto,et al.  Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma. , 1988, Clinical chemistry.

[33]  R. Wallace,et al.  Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease. , 1987, Epidemiologic reviews.

[34]  A. Zinsmeister,et al.  Apolipoproteins and coronary artery disease. , 1986, Mayo Clinic proceedings.

[35]  B E Sobel,et al.  Plasma apoproteins and the severity of coronary artery disease. , 1986, Circulation.

[36]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[37]  N. Al-Muhtaseb,et al.  Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction , 1986 .

[38]  A. Hamsten,et al.  Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. , 1986, Atherosclerosis.

[39]  J. Patsch,et al.  Zonal ultracentrifugation. , 1986, Methods in enzymology.

[40]  M. Blombäck,et al.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.

[41]  K. Hiwada,et al.  Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease. , 1985, Atherosclerosis.

[42]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[43]  W. Gruber,et al.  Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[44]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[45]  T. Meade,et al.  HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY , 1983, The Lancet.

[46]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[47]  S. Mao,et al.  Radioimmunoassay of apolipoprotein A-i. application of a non-ionic detergent (Tween-20) and solid-phase staphylococcus. , 1982, Clinical chemistry.

[48]  E. Lee,et al.  Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. , 1981, Atherosclerosis.

[49]  L. Solberg,et al.  Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study , 1980 .

[50]  G. Assmann,et al.  Lipoprotein and apoprotein values in coronary angiography patients. , 1980, Artery.

[51]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[52]  G. Schonfeld,et al.  The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay. , 1974, The Journal of clinical investigation.

[53]  R. Lees,et al.  Assay of total plasma apolipoprotein B concentration in human subjects. , 1974, The Journal of clinical investigation.

[54]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.